Why the study?
Can molecular techniques (RT-PCR and sequencing) applied to cytology samples confirm the diagnosis of DSRCT?
Can molecular techniques (RT-PCR and sequencing) applied to cytology samples confirm the diagnosis of DSRCT?
Answers are grounded in this paper and cite their sources.
Molecular techniques such as RT-PCR and sequencing can be successfully applied to cytology samples from peritoneal effusions to confirm difficult diagnoses of undifferentiated neoplasms like DSRCT.
Desmoplastic small round cell tumor (DSRCT) is a rare undifferentiated neoplasm. The prognosis is poor, even if therapy is instituted promptly, and thus it is important to differentiate it from other histologically and cytologically similar-looking malignancies of the young adult. We present a case of DSRCT in a 17-yr-old male with disseminated peritoneal disease and peritoneal effusion. The cytology sample showed a malignant small round cell tumor, the classical cytological features of DSRCT, and immunohistochemistry performed in the prepared cell block exhibited an antibody expression profile in keeping with DSRCT. Further material from the effusion was prepared for RNA extraction, following which a reverse-transcriptase polymerase chain reaction (RT-PCR) and sequencing of the t(11;22)(p13;q11 or q12) were carried out. The result showed the presence of the reciprocal translocation and thus confirmed the diagnosis of DSRCT. This case shows how molecular techniques (including sequencing) can be applied to cytology in clarifying and confirming certain difficult diagnosis of undifferentiated neoplasms, DSRCT in this particular case.
No takes yet. Share an insight, caveat, or question.
Chiu et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: